Search

everythinglearnresearchcommunity

for

Search:↓

Preventing hair loss is more effective than regrowth; oral finasteride is a realistic option.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

New oral treatment, finasteride, effectively and safely treats common hair loss.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Estrogen deficiency, like after menopause or certain surgeries, leads to faster skin aging and health issues.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

SFRP2 and PTGDS may be key factors in female hair loss.

Ginseng and Albizia extracts may help prevent age-related hair thinning.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Some breast cancer chemotherapy can cause permanent hair loss.